Loading…
Loading…
See exactly how BIPIX's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for BIPIX and 80,000+ other tickers.
This fund's primary objective is to generate daily investment returns that are one and a half times (1.5x) the daily movement of the Dow Jones U.S. BiotechnologySM Index, before any deductions for fees and expenses. To achieve this leveraged daily exposure, the fund strategically allocates its assets to various financial instruments that the adviser expects will produce results aligned with its specific investment goal. The aforementioned index serves as a benchmark, monitoring the performance of select companies within the biotechnology sector of the American stock market. It is important to note that this fund is not diversified, indicating a concentrated investment strategy.
No recent news available.